Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 148 participants.

Also called NCT05709509

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 148 participants (planned count) (from the registry)
Sponsor
RSD dr. Soebandi (from the registry)
Registry
  • NCT NCT05709509
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05709509. Randomized; no masking; primary purpose treatment. Start 2022-06-01 (actual); primary completion 2023-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
Condition
ST Elevation Myocardial Infarction
Condition
Colchicine
Condition
Cardiac Remodeling, Ventricular
Intervention (Drug)
Colchicine
Intervention (Procedure)
Percutaneous Coronary Intervention
Intervention (Other)
Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.
Lead sponsor
RSD dr. Soebandi (class: other government)
Collaborator
Universitas Jember (class: not stated)
Collaborator
University of Brawijaya (class: other)

Record details

Record id
cardio:ct-nct05709509
Content hash
8699e4e663272c909e39441125391f589184c20d6b753bff0025fbbef0acc110